Genomics in Cancer Care Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Genomics is the study of genes and other molecular components that aids in the identification of genetic features and functions of cells. Genomic analysis is a frequently utilised biotechnological tool that has shown a variety of therapeutic and medicinal benefits. In the medical sector, genomics has made it possible to research cancer and its genetics more efficiently and conveniently. The application of genomics has resulted in the development of novel cancer treatments and preventative measures.

MARKET SCOPE

The Global Genomics In Cancer Care Market Analysis to 2031 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the genomics in cancer care market with detailed market segmentation by product and service, technology, application and end user. The report provides key statistics on the market status of the leading genomics in cancer care market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product and service the market is segmented as, instruments, consumables, and service, software.
  
•   Based on technology the market is segmented as, gene sequencing, PCR, microarray nucleic acid extraction and purification, and others.
  
•   Based on application the market is segmented as, diagnostic, drug delivery, precision medicine, and research.
  
•   Based on end user the market is segmented as, hospitals, diagnostics laboratories, and academic & research institutes.
  

MARKET DYNAMICS
Drivers:

•   Increasing prevalence of cancers across the globe.
  
•   Developments and technological advancements in the field of genomics is expected to spur the market growth.
  
•   Rising R&D expenditures by biopharmaceutical and biotechnological companies to develop precision medicine for cancers.
  

Restraints:

•   However, availabilty of other approaches, high cost associated with genomics study are expected to restrain market growth.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The genomics in cancer care market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the genomics in cancer care market in these regions.

IMPACT OF COVID-19 ON GENOMICS IN CANCER CARE MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Genomics in Cancer Care Market Report Analysis

Genomics in Cancer Care Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Illumina Inc.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• PerkinElmer, Inc.
• QIAGEN
• Abbott
• BGI
• F. Hoffmann La Roche AG
• Bio Rad Laboratories, Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product and Service

• Instruments
• Consumables
• Software and Service

By Technology

• Gene Sequencing
• PCR
• Microarray Nucleic Acid Extraction and Purification

By Application

• Diagnostic
• Drug Delivery
• Precision Medicine
• Research

By End User

• Hospitals
• Diagnostics Laboratories
• Academic and Research Institutes

MARKET PLAYERS

The report covers key developments in the genomics in cancer care market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from genomics in cancer care market are anticipated to lucrative growth opportunities in the future with the rising demand for Genomics in cancer care in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the genomics in cancer care market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Illumina Inc
  
•   Agilent Technologies, Inc
  
•   Thermo Fisher Scientific Inc
  
•   PerkinElmer, Inc.
  
•   QIAGEN
  
•   Abbott
  
•   BGI
  
•   F. Hoffmann La Roche AG
  
•   Bio Rad Laboratories, Inc
  
•   Beckman Coulter, Inc(Danaher)
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Genomics in Cancer Care Market Report Scope